News & Updates
Showing Obstetrics & Gynaecology articles
Showing
Show Multimedia Only

Bivalent HPV vaccine substantially reduces cervical cancer, CIN3 rates
10 Feb 2022
byRoshini Claire Anthony
The risk of cervical cancer and grade 3 cervical intraepithelial neoplasia (CIN3) was substantially reduced among girls who were offered the bivalent human papillomavirus (HPV) vaccine, particularly those who were offered it at age 12–13 years, according to an observational study from England.
10 Feb 2022







